We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $481M
1-Year Est. Return 35.73%
This Fund
S&P 500
This Quarter Est. Return
+1.38%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$349M
AUM Growth
-$2.6M
Cap. Flow
-$4.7M
Cap. Flow %
-1.35%
Top 10 Hldgs %
72.52%
Holding
51
New
4
Increased
8
Reduced
32
Closed
2

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.41M
2
AZN icon
AstraZeneca
AZN
+$2.71M
3
IDXX icon
Idexx Laboratories
IDXX
+$339K
4
AMD icon
Advanced Micro Devices
AMD
+$290K
5
NOW icon
ServiceNow
NOW
+$245K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$4.11M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.67M
3
AAPL icon
Apple
AAPL
+$770K
4
ISRG icon
Intuitive Surgical
ISRG
+$393K
5
BAND
Bandwidth Inc
BAND
+$371K

Sector Composition

Rank Sector Weight
1 Technology 33.37%
2 Consumer Discretionary 29.92%
3 Healthcare 21.28%
4 Communication Services 12.55%
5 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
26
NextEra Energy
NEE
$171B
$2.74M 0.78%
34,908
-98
-0.3% -$7.9K
LLY icon
27
Eli Lilly
LLY
$1.05T
$2.09M 0.6%
9,044
+5
+0.1% +$1.23K
AMD icon
28
Advanced Micro Devices
AMD
$760B
$1.37M 0.39%
13,308
+2,840
+27% +$290K
PRLB icon
29
Protolabs
PRLB
$1.91B
$1.36M 0.39%
20,385
-3,015
-13% -$236K
EXEL icon
30
Exelixis
EXEL
$13.5B
$1.24M 0.35%
58,469
-14,746
-20% -$274K
ABT icon
31
Abbott
ABT
$195B
$1.06M 0.3%
8,976
-120
-1% -$14.7K
BMY icon
32
Bristol-Myers Squibb
BMY
$136B
$913K 0.26%
15,425
+66
+0.4% +$4.35K
NSC icon
33
Norfolk Southern
NSC
$78.3B
$860K 0.25%
3,595
-135
-4% -$34.6K
COST icon
34
Costco
COST
$419B
$846K 0.24%
1,883
– –
BA icon
35
Boeing
BA
$166B
$838K 0.24%
3,809
-80
-2% -$17.8K
JNJ icon
36
Johnson & Johnson
JNJ
$646B
$805K 0.23%
4,986
-35
-0.7% -$5.97K
JPM icon
37
JPMorgan Chase
JPM
$951B
$697K 0.2%
4,261
-18
-0.4% -$2.82K
PFE icon
38
Pfizer
PFE
$159B
$577K 0.17%
13,417
+30
+0.2% +$1.33K
PAYX icon
39
Paychex
PAYX
$45.2B
$541K 0.15%
4,810
-60
-1% -$6.74K
TROW icon
40
T. Rowe Price
TROW
$23.7B
$491K 0.14%
2,495
-20
-0.8% -$4.21K
TGT icon
41
Target
TGT
$74.1B
$490K 0.14%
2,140
– –
MRK icon
42
Merck
MRK
$366B
$484K 0.14%
6,442
+50
+0.8% +$3.8K
DE icon
43
Deere & Co
DE
$170B
$472K 0.14%
1,410
-40
-3% -$14.4K
NUE icon
44
Nucor
NUE
$56.8B
$431K 0.12%
4,375
– –
CAT icon
45
Caterpillar
CAT
$368B
$326K 0.09%
1,697
– –
IDXX icon
46
Idexx Laboratories
IDXX
$43.7B
$314K 0.09%
+505
New +$339K
DUK icon
47
Duke Energy
DUK
$93.8B
$256K 0.07%
2,626
– –
NOW icon
48
ServiceNow
NOW
$150B
$252K 0.07%
+2,025
New +$245K
HON icon
49
Honeywell
HON
$68.9B
$212K 0.06%
+1,061
New +$226K
VZ icon
50
Verizon
VZ
$208B
– –
-3,874
Closed -$217K
1
2
3

Similar funds

MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $481M AUM 22.61% 1-Year Est. Return
SA
Stewardship Advisors Mount Joy, Pennsylvania $481M AUM 18.41% 1-Year Est. Return
NC
NovaPoint Capital Atlanta, Georgia $481M AUM 32.01% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
MAV
Mason & Associates (Virginia) Newport News, Virginia $481M AUM 12.85% 1-Year Est. Return
OMIC
Old Mission Investment Co Traverse City, Michigan $481M AUM
SCA
Sage Capital Advisors Sioux Falls, South Dakota $482M AUM 34.73% 1-Year Est. Return

Bender Robert & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Bender Robert & Associates held 51 positions worth $349M, down 0.74% from $352M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bender Robert & Associates's Q3 2021 filing shows 4 new, 8 increased, 32 reduced and 2 closed positions. Its largest new stake was AstraZeneca: 23,290 shares worth $2.8M. The largest sale was Alexion Pharmaceuticals, an estimated $4.11M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q3 2021 buy was AstraZeneca: 23,290 shares worth $2.8M.
  • Bender Robert & Associates added most to Alphabet (Google) Class C in Q3 2021, an estimated $3.41M increase.
  • Bender Robert & Associates's biggest Q3 2021 reduction was Alphabet (Google) Class A, cutting an estimated $3.67M.
  • Bender Robert & Associates fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.11M.
  • Bender Robert & Associates's ten largest holdings make up 73% of its $349M portfolio in Q3 2021.
  • Bender Robert & Associates opened 4 new positions and closed 2 in Q3 2021.
  • Bender Robert & Associates's portfolio value fell 0.74% quarter-over-quarter to $349M.

Based on Bender Robert & Associates's 13F filing for Q3 2021, filed 3 Nov 2021.